Risk Factors Prediction, Clinical Outcomes and Mortality of COVID‐19 Patients

alkiviadis.1961 shared this article with you from Inoreader Message: X Risk Factors Prediction, Clinical Outcomes and Mortality of COVID‐19 Patients Via Journal of Medical Virology Abstract Preventing communicable diseases requires understanding the spread, epidemiology, clinical features, progression, and prognosis of the disease. Early identification of risk factors and clinical outcomes might help to identify critically ill patients, provide proper treatment and prevent mortality. We conducted a prospective study in patients with flu‐like symptoms referred to the imaging department of a tertiary hospital in IRAN between 3 March 2020 and 8 April 2020. Patients with COVID‐19 were followed up to check their health condition after two months. The categorical data between groups were analyzed by Fisher's exact test and continuous data by Wilcoxon Rank‐Sum Test. 319 patients (mean age 45.48±18.50 years, 177 women) were enrolled. Fever, dyspnea, weakness, shivering, C‐reactive protein (CRP), fatigue, dry cough, anorexia, anosmia, ageusia, dizziness, sweating and age were the most important symptoms of COVID‐19 infection. Traveling in past three months, asthma, taking corticosteroids, liver disease, rheumatological disease, cough with sputum, eczema, conjunctivitis, tobacco use, and chest pain did not have any relationship with COVID‐19. To the best of our knowledge, some of the effective features on the mortality due to COVID‐19 are investigated for the first time in this research. This study may prove helpful in early prediction and risk reduction of mortality in patients infected with COVID‐19. This article is protected by copyright. All rights reserved. View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.